Ownership history in Monaco Asset Management SAM · 13 quarters on record
This page tracks every 13F SEC filing in which Monaco Asset Management SAM reported a position in FATE THERAPEUTICS INC (FATE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 830,000 | +60,000 | +7.8% | 0.14% | $816K | $0.98 |
| 2025 Q3 | ADDED | 770,000 | +95,000 | +14.1% | 0.06% | $970K | $1.26 |
| 2025 Q2 | REDUCED | 675,000 | -474,708 | -41.3% | 0.13% | $756K | $1.12 |
| 2025 Q1 | ADDED | 1,149,708 | +822,037 | +250.9% | 0.19% | $908K | $0.79 |
| 2024 Q4 | ADDED | 327,671 | +190,000 | +138.0% | 0.08% | $541K | $1.65 |
| 2024 Q3 | REDUCED | 137,671 | -149,229 | -52.0% | 0.07% | $482K | $3.50 |
| 2024 Q2 | REDUCED | 286,900 | -29,905 | -9.4% | 0.15% | $941K | $3.28 |
| 2024 Q1 | REDUCED | 316,805 | -1,866,423 | -85.5% | 0.70% | $2.3M | $7.34 |
| 2023 Q4 | ADDED | 2,183,228 | +335,284 | +18.1% | 2.40% | $8.2M | $3.74 |
| 2023 Q3 | ADDED | 1,847,944 | +842,718 | +83.8% | 1.16% | $3.9M | $2.12 |
As of 2025 Q4 — sorted by position size